Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...
The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback